OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics
Poonam R. Pandey, Ken H. Young, Dhiraj Kumar, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Next-Generation Sequencing Technology: Current Trends and Advancements
Heena Satam, Kandarp Joshi, Upasana Mangrolia, et al.
Biology (2023) Vol. 12, Iss. 7, pp. 997-997
Open Access | Times Cited: 473

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Liping Pei, Yang Liu, Lin Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 111

Lipid nanoparticles for siRNA delivery in cancer treatment
Souhaila H. El Moukhtari, Elisa Garbayo, Ane Amundarain, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 130-146
Closed Access | Times Cited: 62

Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development
Abdolmajid Ghasemian, Hadeel A. Omear, Yaser Mansoori, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 44

Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 19

Immunotherapy: an alternative promising therapeutic approach against cancers
Sneh Lata Gupta, Srijani Basu, Vijay Soni, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9903-9913
Open Access | Times Cited: 62

Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58

Modulating T Cell Responses by Targeting CD3
Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1189-1189
Open Access | Times Cited: 39

Transfer RNA-derived small RNAs in tumor microenvironment
Mei Yang, Yongzhen Mo, Daixi Ren, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 32

High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 13
Closed Access | Times Cited: 24

Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers‐Mediated Photodynamic Therapy
Qing Yu, Xia Li, Juan Wang, et al.
Small (2023) Vol. 20, Iss. 16
Closed Access | Times Cited: 23

The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 13

Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12

ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges
Jong Won Lee, Man Kyu Shim, Hyo‐Suk Kim, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115073-115073
Open Access | Times Cited: 16

Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma
Xier Pan, Shuting Ni, Kaili Hu
Biomaterials (2024) Vol. 306, pp. 122481-122481
Closed Access | Times Cited: 7

RNA nanostructures for targeted drug delivery and imaging
Laura Teodori, Marjan Omer, Jørgen Kjems
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-19
Open Access | Times Cited: 7

Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
Juliana Brandstetter Vilar, Markus Christmann, Maja Tomičić
Cancers (2022) Vol. 14, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 24

The immunomodulatory effects of RNA-based biomaterials on bone regeneration
Chenyu Wang, Zixuan Qin, Yu Wei, et al.
Acta Biomaterialia (2023) Vol. 162, pp. 32-43
Closed Access | Times Cited: 15

Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis
Xiangkun Wu, Hong Yan, Mingxing Qiu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 14

TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy
Shixiang Wang, Yi Xiong, Yihao Zhang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008040-e008040
Open Access | Times Cited: 5

Recent advanced lipid-based nanomedicines for overcoming cancer resistance
Piroonrat Dechbumroong, Runjing Hu, Wisawat Keaswejjareansuk, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5

RNA nanotherapeutics for hepatocellular carcinoma treatment
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5

Immunomodulation in Bone Tissue Engineering: Recent Advancements in Scaffold Design and Biological Modifications for Enhanced Regeneration
Niloufar Abedi, Aida Sadeghian, Monireh Kouhi, et al.
ACS Biomaterials Science & Engineering (2025)
Closed Access

Page 1 - Next Page

Scroll to top